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Abstract
This is a protocol for a Campbell Evidence and Gap Map. The objectives are to
identify and assess the available evidence on health, social care and technological
interventions to improve functional ability among older adults.
1 | BACKGROUND
1.1 | Introduction
1.1.1 | The problem, condition or issue
There is an increasing proportion of older adults in the global population,
with UN population projections predicting that before 2020, people aged
>65 years will outnumber children aged <5 years for the first time in
history (United, 2017). Low‐ and middle income countries such as China
and India are expected to experience a rapid rise in population ageing,
compared to Western Europe (United, 2017). Currently, over two thirds
of people over 65 years of age are living with multi‐morbidities
(Banerjee, 2015). When combined with parallel increases in disparities to
health care and broader determinants of health (Sadana, Blas, Budhwani,
Koller, & Paraje, 2016), there are major implications for health and social
care systems (Beard et al., 2016; Chatterji, Byles, Cutler, Seeman, &
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Verdes, 2015; Prince Martin et al., 2015). While many nations are
becoming wealthy with the influx of global socioeconomic developments,
many countries, especially low‐ and middle income countries, have
experienced increasing health and social disparities, especially among
older adults (WHO, 2015). Older adults with the greatest health needs
are also often those with the fewest resources to support them (Beard
et al., 2016). For example, older adults in low‐ and middle income
countries have poor access to assistive technologies and medical devices,
as a result of a confluence of factors that affect the availability of these
products in local markets including affordability and appropriateness,
which can influence their availability, accessibility, and integration into
health and social systems (Garçon et al., 2016; Marasinghe, Lapitan, &
Ross, 2015). Furthermore, the privatization of health and social services
becomes a barrier to quality of care if costs impact access to appropriate
and timely care for older adults. Functional ability is complex and
comprises an individual’s intrinsic capacity and people's interaction with
their environment, including environmental characteristics that enable
people to be and do what they value (Cesari et al., 2018; WHO, 2015).
TheWHO considers intrinsic capacity to include the physical and mental
capacities of a person. Likewise, the environment defined by the WHO
includes all factors in the extrinsic world that form the context of an
individual’s life. For example, the home, community and society are
included alongside the built environment, interpersonal relationships,
attitudes, values, health and social policies, and the systems that support
individuals and services (WHO, 2015).The Priority Assistive Products
List of essential assistive devices that includes wheelchairs, pill
organizers, hearing aids, and other essential items for many older people
and people with disabilities to be able to live a healthy and dignified life
and mitigate declines in intrinsic capacity (World, 2016).
The accumulation of exposures and environmental influences
throughout the life course can influence the development of different
risk factors that lead to chronic diseases, injuries, or other age‐related
issues that contribute to declines in intrinsic capacities. Without a
supportive environment, whether social or built, this will result in
diminished functional ability. The gradual decline in intrinsic capacities as
some people age can require increased health and social care services
from informal (i.e., family or friends) and formal caregivers (i.e., health
professionals). Increased care needs lead to increased burden on families,
stress for older adults, and costs to society. For this reason, efforts to
deliver cost efficient, effective interventions that optimize functional
ability at any level of intrinsic capacity, is critical for older adults. Health
and social care interventions (including assistive health technologies), and
related systems, services and policies may include technological tools and
devices and provision of health and social supports in the home.
While it is important to offer home‐based supports that promote
functional ability, we need to be mindful that existing health inequities
may be worsened (Sadana et al., 2016; Gottlieb & Alderwick, 2019). For
example, if health and social services are provided privately and not
covered by the health system or health insurance, all individuals will not
have the same opportunities to achieve optimal health. Furthermore, the
diagnosis, management and treatment of chronic health conditions in
older adults can be prone to age‐based, unconscious bias and explicit
discrimination, which can lead to less than optimal care (Cherubini,
Corsonello, & Lattanzio, 2012; Drury, Abrams, Swift Hannah, Lamont
Ruth, & Gerocova, 2017). Likewise, age‐based bias is seen in research on
conditions that affect older adults such as stroke and osteoarthritis, with
the median age of participants over 10 years younger than the typical
patient (Gaynor, Geoghegan, & O'Neill, 2014; Liberopoulos, Trikalinos
Nikolaos, & Ioannidis John, 2009).
1.2 | The intervention
1.2.1 | Why it is important to develop the evidence
and gap maps
An estimated >85% of research investment is wasted (Chalmers &
Glasziou, 2009), some of which could be avoided by prioritizing
research, including rigorous evaluation of existing evidence using
systematic reviews (SR) prior to funding or carrying out new research
(Chalmers et al., 2014). An evidence and gap maps (EGM) is a
decision making and research prioritization tool that highlights gaps
in research to inform strategic health and social policy, program and
research priorities (Snilstveit, Vojtkova, Bhavsar, & Gaarder, 2013).
EGMs can be used to avoid needless duplication, and can also be used
to identify where sufficient, high quality evidence from systematic
reviews and randomized trials are available as a basis for decisions or
where sufficient studies are available for knowledge synthesis
(Snilstveit, Vojtkova, Bhavsar, Stevenson, & Gaarder, 2016).
This EGM is important to inform policy and research prioritization.
It is aligned with the WHO Strategy and Action Plan on Ageing and
Health 2016–2020,. At the sixty‐ninth World Health Assembly in May
2016, the World Health Organization (2016) launched and received
endorsement from all 193 member states for the WHO Strategy and
Action Plan on Ageing and Health 2016‐2020. This plan outlined five
strategic objectives: (a) commitment to action on healthy ageing in
every country; (b) developing age‐friendly environments; (c) aligning
health systems to the needs of older populations; (d) developing
sustainable and equitable systems for providing long‐term care; (e)
improving measurement, monitoring and research on healthy active
ageing. The WHO aims to meet these by implementing evidence‐based
actions to maximize functional ability of every individual (World, 2016).
In this way the process of “optimizing opportunities for health,
participation and security will enhance the quality of life as people
age” (WHO, 2015). This EGM is relevant to the first objective – a
commitment to action on healthy ageing in every country. Furthermore,
our objectives align with the United Nations Sustainable Development
Goals and the objectives of the UN High Level meeting on preventing
and controlling non‐communicable diseases (United, 2018, 2019).
We will take a health systems perspective to extend the focus from
health care to include social care and technological interventions. The
evidence will be presented in terms of functional ability. We will also
consider determinants of health inequity. The proposed EGM will
consider the multi‐faceted and complex nature of functional ability and
the various mechanisms (e.g., services, products, and individuals) involved
in supporting functional ability among ageing adults.
We have a broad range of intended user groups including
practitioners, researchers, policy/decision‐makers, and the public.
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We have also included three stakeholder groups as authors and
advisory members: the WHO Department of Ageing and Life Course
(RS), Cochrane Global Ageing (JTC) and the Campbell Ageing group
(JTC). Each of these intended users are included as authors on the
EGM and have participated in defining the intervention and outcome
framework. The EGM will be used to identify the best quality
evidence to guide decision making in this area. It will also help to
identify gaps in the evidence base both in terms of evidence
syntheses and primary research and thereby facilitate the prioritiza-
tion of topics for further research.
Currently, no EGMs exist that identify and assess the available
evidence on health, social care, and technological interventions to
improve functional ability among older adults.
2 | OBJECTIVES
The objectives are to:
• Identify available systematic reviews and randomized trials.
• Identify areas where systematic reviews are needed.
• Identify gaps in evidence where further primary research is
needed.
• Assess equity considerations in available systematic reviews and
randomized trials.
• Assess gaps and evidence related to health equity.
3 | METHODS
3.1 | Evidence and gap map: definition and purpose
We will adapt evidence gap map methods from various key
papers (Bragge et al., 2011; Lum, Koper Christopher, & Telep
Cody, 2011; Snilstveit et al., 2013, 2016) and will adopt a five‐
stage process:
• Define a framework.
• Identify the available evidence.
• Appraise the quality of the evidence.
• Extract, code and summarize the data that relate to the objectives.
• Visualization and presentation of the findings in a user‐friendly
manner.
We will use the Campbell Collaboration mapping tool developed
by the EPPI‐Centre (Eppi‐Centre, 2019) to display identified studies
using the framework described below.
3.2 | Framework development and scope
The framework was developed following a meeting with methodol-
ogists, practitioners, decision‐makers and consumers at the Cochrane
Colloquium during the 2017 Global Evidence Summit. Meeting
participants suggested using the International Classification of
Functioning (ICF) framework to define the intervention focus for
this EGM as well as the outcomes. We further defined the scope of
the framework in consultation with our research team which includes
input from the public (AL), practitioners (LS, PT, KP, JN, ET, PW),
information scientist (MR), policy‐makers (RS, HS) and researchers
(VW, SM, JTC, MGC, EK, BS, AS, WZ).
The EGM framework will inform the inclusion and exclusion
criteria. Key dimensions of the framework are listed below. We will
follow the standard EGM framework as a matrix where the rows are
intervention domains, and the columns are outcome categories. The
interventions and outcomes will have sub‐categories.
Maintaining autonomy and independence, especially being able to
make their own choices and decisions, are important for older adults
in all settings (Hillcoat‐Nalletamby, 2014; Plath, 2009; Welford,
Murphy, Rodgers, & Frauenlob, 2012). The concept of home is
defined broadly, as the place of dwelling in which older adults seek to
maintain their autonomy. This can include residential homes, long‐
term care facilities, hospices, nursing homes and any non‐acute care
places of residence. This EGM will identify health and social support
services as well as technological interventions that optimize
functional ability among older adults by systematically collecting,
identifying, and mapping available evidence. In order to reflect the
most relevant interventions and outcomes associated with support-
ing functional ability among older adults, we adapted the ICF
framework and (WHO, 2001; Sadana & Posarac, 2018). The ICF is a
comprehensive framework used by the WHO to measure health and
disability at both individual and population levels. The WHO is also
using the ICF as the basis to operationalize the measurement of
intrinsic capacities, functional ability, and enabling environments
(Sadana & Posarac, 2018)
Given the importance of the home setting in optimizing functional
ability in older adults and in consultation with our advisory group, we
are interested in technological interventions that support mobility at
home (e.g., walking devices, ramps), social care services (e.g.,
homemaking, personal care) and health care services (e.g., covering
promotive, preventive, treatment, rehabilitative, whether long‐term,
provided by family physician visits or other health workers) delivered
in the home setting.
3.3 | Stakeholder engagement
We have created an Advisory Group comprised of methodologists,
physicians (and other health‐care professionals), consumers and
researchers with expertize in assistive health technology, healthy
ageing, long‐term care, rehabilitation, disability, memory, and
cognitive impairment. We held an exploratory meeting to invite
feedback on the development of our EGM framework at the Global
Evidence Summit in Cape Town, September 2017. The participants
included family practitioners, geriatricians, social workers, and
methodologists. We also held a seminar at the Bruyère Research
Institute Grand Rounds (October 26, 2017) with family practitioner‐
researchers, where participants provided feedback on the interven-
tion‐outcome framework. Our decision to focus on the selected
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intervention categories was also informed by public engagement
through our public representative (AL). Our central team (VW, TH,
SM, PB, and CM) plans to meet at least once a month to discuss the
direction and scope of the EGM.
3.4 | Conceptual framework
Figure 1 below demonstrates the conceptual framework through
which the inputs lead to the intended outcomes. A person's intrinsic
capacity is dependent on their health characteristics (e.g., health‐
related behaviors, disease, or injuries), genetic inheritance, and
personal characteristics (e.g., sex/gender or ethnicity). However, the
extent to which an individual accomplishes what they value is also
dependent on functional ability and their interactions with the
environment, Enabling environments (i.e., services, systems and
policies, and products and technology), when implemented within a
home context, can influence outcomes such as improved neuro‐
musculoskeletal functioning, through the use of an external aid,
assistance by another person or improvement in the built environ-
ment. Supportive environments can strongly influence functional
ability in the home among older adults. We also included health
inequalities as an outcome of interest because we are aware that
certain characteristics may stratify or impact health opportunities
and outcome, such as socioeconomic status or place of residence.
We will review and update our conceptual framework as we
develop the map.
4 | DIMENSIONS
4.1 | Types of study design
We will include randomized trials and systematic reviews of both
randomized and nonrandomized trials that meet our inclusion
criteria. We define a systematic review according to the PRISMA
definition, which encompasses articles that specifically stated
methods used to identify studies (i.e., a search strategy),
strategies for study selection (e.g., eligibility criteria and selection
process) and explicitly detailed methods of synthesis (Moher
et al., 2015). This study design, as defined by PRISMA, uses a
transparent and an a priori methodology in order to ensure rigor.
We will exclude systematic reviews of predictive factors,
prognostic and diagnostic studies, and studies that primarily analyze
F IGURE 1 Conceptual framework [Color figure can be viewed at wileyonlinelibrary.com]
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implementation, barriers and facilitators to effectiveness (Snilstveit
et al., 2013).
Since the aim of the EGM is to inform priorities for systematic
reviews and knowledge exchange activities, we will also include on‐
going systematic reviews and randomized trials. We will also include
studies published in gray literature such as reports, dissertations, and
conference abstracts.
We do not plan to include qualitative research.
4.2 | Types of intervention/problem
We will contextualize interventions according to the ICF categoriza-
tion of environmental factors. This will be further divided into:
1. Products and technology related to mobility: The ICF provides a
very comprehensive list of eligible interventions. We will
specifically examine section e1201 and e155 from the ICF that
comprises assistive products and technology for personal indoor
and outdoor mobility and transportation as well as design,
construction, and building products and technology of buildings
for private use. This includes products such as wheelchairs,
walking devices, transfer devices, and ramps.
2. Health and social services, systems and policies: While we
recognize that systems and policies can have an impact on the
individual, we will specifically focus on sections e5750 and e5800,
which includes health and social support services provided at
home such as homemaking, personal care, health care profes-
sional home visits, or long‐term care.
We decided to limit the scope of the ICF framework due to
feasibility. Specifically, we will exclude studies of pharmacological
interventions, therapies, telemedicine or telecare, educational
programs, and any hospital‐based programs. We will also exclude
any studies that examine caregiver support services exclusively
without evaluating outcomes related to older adults. A compre-
hensive list of interventions in each category may be found in
Table 1.
4.3 | Types of population (as applicable)
This EGM will focus on adults over the age of 60 years, using the
United Nations cut off for older or elderly individuals (United, 2015),
and particularly those over 75 years of age. Studies and reviews will
be included if at least 50% of the sample population is greater than
60 years old.
4.4 | Types of outcome measures (as applicable)
We will map the evidence on outcomes that fall into one of the
following ICF (WHO, 2001). adapted categories: impairments to body
functions and structures (expressed as intrinsic capacities), and
functional ability. We will also include process and other outcomes
that may also have an effect on a particular outcome. We will
consider health inequities by examining environmental and personal
attributes that may stratify health opportunities and outcomes, using
the PROGRESS framework (O'Neill et al., 2014). Our outcomes
framework is provided in Table 3.
Intrinsic capacity will consist of mental (e.g., depression, sleep,
vitality); sensory functions and pain (e.g., vision, hearing); neuro‐
musculoskeletal function (e.g., gait, balance); voice and speech (e.g.,
articulation); cardiovascular, hematological, immune, respiratory
system function (e.g., blood pressure, respiration); digestive, endo-
crine, metabolic functions (e.g., thyroid, glucose); genitourinary and
reproductive function (e.g., bladder control); and integumentary
system function (e.g., skin, nails).
Functional ability will consist of the following constructs: basic
needs (e.g., self‐care, acquisition of goods and services); learning
and applying knowledge (e.g., applying knowledge); contribution
(e.g., community life, employment); mobility (e.g., walking);
relationships (e.g., interpersonal interactions); and communication
(e.g., language).
Process and other outcomes will include cost (out of pocket),
cost‐effectiveness, falls, satisfaction of older adult, safety, caregiver
outcomes, adherence, health service utilization, quality of life,
financial security, access, and stigma. Access is a multi‐faceted
concept and can be understood as the opportunity or ease with
which consumers or communities are able to use appropriate
services in proportion to their needs (Daniels, 1982; Whitehead,
1992). The concept of access will include: acceptability, approach-
ability, availability and accommodation, affordability and appropri-
ateness (Levesque, Harris Mark, & Russell, 2013).
We will use the PROGRESS framework to identify studies that
measured effects of interventions by gender or other health
inequalities.
4.5 | Other eligibility criteria
4.5.1 | Types of settings
We will include interventions in the home setting for older adults. We
will define home as an individual’s place of residence that can include
residential homes, apartments, long‐term care facilities, hospices,
nursing homes and any nonacute care places of residence. Studies of
mixed settings will be included as long as the intervention takes place
in the home setting at least 50% of the time. We will code the settings
so that the evidence can be filtered according to setting.
Acute and sub‐acute hospital and convalescent care settings will
be excluded (e.g., geriatric rehabilitation in subacute care).
4.6 | Search methods and sources
We will develop and pilot a search strategy (with a selection of
studies that met our inclusion criteria) with the guidance of an
information scientist (MR). This search will comprise of the medical
and health databases ( MEDLINE (via OvidSp), EMBASE (via OvidSp),
Cochrane Database of Systematic Reviews, CENTRAL, CINAHL (Via
EBSCOhost), PsychINFO (via OvidSp) and AgeLine (via EBSCOhost)
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and databases relevant to social care and social policy (Campbell
Library, ASSIA (via ProQuest), Social Science Citation Index (via Web
of Science) and Social Policy and Practive (via OvidSp). See Table 2
for full search strategy.
We will search for relevant trials and systematic reviews in the
gray literature via ProQuest Theses and Dissertation Global and via
Conference Proceedings Citation Index. We will also search for
relevant unpublished studies via relevant international organizations
(e.g., Help Age, World Health Organization, and Institute for
Research on Public Policy).
Ongoing systematic reviews will be identified by searching
for protocols in PROSPERO and the Cochrane and Campbell libraries
TABLE 1 Interventions framework (based on the ICF)
Intervention
category Focus Definition Specific examples
Services, Systems
and Policies
e575 General social support
services, systems and
policies
Services, systems and policies aimed at
providing support to those requiring
assistance in areas such as shopping,
housework, transport, child care, self‐
care and care of others, in order to
function more fully in society.
e5750 General social support servicesServices
and programs aimed at providing social support
to people who, because of age, poverty,
unemployment, health condition or disability,
require public assistance in the areas of
shopping, housework, transport, self‐care and
care of others, in order to function more fully in
society.
Exclusions: social security services,
systems and policies (e570);
personal care providers and personal
assistants (e340); health services,
systems and policies (e580)
e580 Health services,
systems and policies
e5800 Health services
Services, systems and policies for
preventing and treating health problems,
providing medical rehabilitation and
promoting a healthy lifestyle. Exclusions:
general social support services, systems
and policies
Services and programmes at a local, community,
regional, state or national level, aimed at
delivering interventions to individuals for their
physical, psychological and social well‐being,
such as health promotion and disease
prevention services, primary care services,
acute care, rehabilitation and long‐term care
services; services that are publicly or privately
funded, delivered on a short‐term, long‐term,
periodic or onetime basis, in a variety of service
settings such as community, home‐based,
school and work settings, general hospitals,
specialty hospitals, clinics, and residential and
non‐residential
Products and
Technology
e120 Products and
technology for personal
indoor and outdoor mobility
and transportation
Equipment, products and technologies
used by people in activities of moving
inside and outside buildings, including
those adapted or specially designed,
located in, on or near the person using
them.Inclusions: general and assistive
products and technology for personal
indoor and outdoor mobility and
transportation
e1201 Assistive products and technology for
personal indoor and outdoor mobility and
transportation.Adapted or specially designed
equipment, products and technologies that
assist people to move inside and outside
buildings, such as walking devices (such as
canes or crutches), special cars and vans,
adaptations to vehicles, wheelchairs, scooters
and transfer devices.
e155 Design, construction
and building products and
technology of buildings for
private use
Products and technology that constitute
an individual's indoor and outdoor
human‐made environment that is
planned, designed and constructed for
private use (e.g. home, dwelling),
including those adapted or specially
designed. Inclusions: entry and exits,
facilities and routing
e1550 Design, construction and building
products and technology for entering and
exiting of buildings for private use Products and
technology of entry and exit from the human‐
made environment that is planned, designed
and constructed for private use, such as entries
and exits to private homes, portable and
stationary ramps, power‐assisted doors, lever
door handles and level door thresholds.
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TABLE 2 Search strategy for MEDLINE
Category Terms
Population 1 exp Aged/pc, px, rh [Prevention & Control,
Psychology, Rehabilitation] (8053)
2 "Aged, 80 and over"/ (806254)
3 Frail Elderly/ (9588)
4 elderly.ti,ab. (219354)
5 older people.ti,ab. (23442)
6 older adult*.ti,ab. (61366)
7 older men.ti,ab. (7857)
8 older women.ti,ab. (12791)
9 old* age*.ti,ab. (65408)
10 pensioners.ti,ab. (793)
11 retirement.ti,ab. (11779)
12 "end of life".ti,ab. (18653)
13 (Resident* and (old* or home* or retirement or
nursing)).ti,ab. (38765)
14 geriatric*.ti,ab. (41516)
15 (veteran* and (old* or home* or retire*)).ti,ab.
(5047)
16 or/1‐15 (1121318)
17 exp Self‐Help Devices/ (10537)
18 exp Orthopedic Equipment/ (92047)
Intervention 19 assistive devices.ti,ab. (1494)
20 assistive equipment.ti,ab. (39)
21 mobility equipment.ti,ab. (20)
22 mobility device*.ti,ab. (311)
23 mobility aid*.ti,ab. (276)
24 motility.ti,ab. (85101)
25 (walking adj2 (device* or aid* or
equipment)).ti,ab. (1248)
26 cane*.ti,ab. (5734)
27 crutches.ti,ab. (1155)
28 walking stick*.ti,ab. (202)
29 (Adapt* adj3 (cars or transport or
vehicles)).ti,ab. (506)
30 (Adapt* adj3 (home* or house*)).ti,ab. (1545)
31 Wheelchair*.ti,ab. (6462)
32 exp Bathroom Equipment/ (10)
33 scooter*.ti,ab. (368)
34 transfer device*.ti,ab. (231)
35 (communication adj (aid* or device*)).ti,ab.
(858)
36 exp Optical devices/ (88276)
37 Hearing aids/ (7984)
38 eyeglasses.ti,ab. (683)
39 glasses.ti,ab. (10746)
40 spectacles.ti,ab. (2316)
(Continues)
TABLE 2 (Continued)
Category Terms
41 hearing device*.ti,ab. (512)
42 hearing aid*.ti,ab. (8346)
43 vision aid*.ti,ab. (364)
44 ((Adapt* or adjust*) adj3 (door* or entry or
exit)).ti,ab. (239)
45 Stair lift*.ti,ab. (2)
46 stair climbing.ti,ab. (1444)
47 stairs.ti,ab. (2902)
48 stair rails.ti,ab. (2)
49 shallow steps.ti,ab. (0)
50 (ramp or ramps).ti,ab. (7094)
51 Home Care Services/ (31353)
52 home care service*.ti,ab. (1605)
53 home support service*.ti,ab. (59)
54 home visit*.ti,ab. (7662)
55 community services.ti,ab. (2375)
56 shopping.ti,ab. (3322)
57 house help.ti,ab. (1)
58 home help.ti,ab. (411)
59 (food adj (preparation or assistance or help or
service or delivery)).ti,ab. (3932)
60 (meal* adj3 (provision or assistance or help or
service* or preparation or delivery)).ti,ab. (1137)
61 homemaking.ti,ab. (109)
62 housekeeping.ti,ab. (8477)
63 ((household or ktichen or routine) adj (jobs or
tasks or chores)).ti,ab. (888)
64 bathing.ti,ab. (9571)
65 grooming.ti,ab. (5015)
66 personal hygiene.ti,ab. (1847)
67 toileting.ti,ab. (857)
68 foot care.ti,ab. (1270)
69 (medication adj2 reminders).ti,ab. (147)
70 (kitchen or bathroom or bedroom).ti,ab.
(5694)
71 or/17‐70 (400411)
Outcomes 72 exp "Activities of Daily Living"/ (63476)
73 Human Activities/ (2170)
74 Automobile Driving/ (17307)
75 Leisure Activities/ (7897)
76 "activities of daily living".ti,ab. (22139)
77 "quality of life".ti,ab. (229433)
78 "Quality of Life"/ (164112)
79 independence.ti,ab. (36023)
80 wellbeing.ti,ab. (11362)
82 social participation.ti,ab. (2177)
(Continues)
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as well as on the open science framework (https://osf.io/). Ongoing
randomized trials will be searched in ClinicalTrials.gov and the WHO
International Clinical Trials Registry Platform.
5 | ANALYSIS AND PRESENTATION
5.1 | Report structure
The EGM report will include the following sections: executive
summary, background, methods, results, and conclusion. The
TABLE 2 (Continued)
Category Terms
83 happiness.ti,ab. (5642)
84 happier.ti,ab. (734)
85 mental health.ti,ab. (116393)
86 functional ability.ti,ab. (4311)
87 depression.ti,ab. (289365)
88 cognitive.ti,ab. (296200)
89 sensory function*.ti,ab. (3884)
90 pain.ti,ab. (543562)
91 distress.ti,ab. (97018)
92 vitality.ti,ab. (10533)
93 energy.ti,ab. (544017)
94 fatigue.ti,ab. (80717)
95 tiredness.ti,ab. (3430)
96 self care.ti,ab. (14789)
97 self efficacy.ti,ab. (21966)
98 mobility.ti,ab. (123516)
99 community life.ti,ab. (457)
100 security.ti,ab. (38430)
101 relationships.ti,ab. (322577)
102 satisfaction.ti,ab. (113208)
103 adherence.ti,ab. (98155)
104 reablement.ti,ab. (49)
105 institutionali?ation.ti,ab. (4370)106 or/72‐
105 (2682926)
107 systematic*.ti,ab. (374866)
108 (meta‐analysis or metaanalysis).ti,ab.
(112568)
109 (review* and (literature or studies or
trials)).ab. (693115)
110 review.ti. (393065)
111 (evidence adj2 synthesi*).ti,ab. (5932)
112 overview.ti,ab. (139107)
113 pubmed.ab. (82182)
114 medline.ab. (94705)
115 or/107‐114 (1336239)
Study Design 116 randomized controlled trial.pt. (464926)
117 controlled clinical trial.pt. (92516)
118 randomized.ti,ab. (448898)
119 randomly.ab. (294026)
120 trial.ti,ab. (509010)
121 groups.ab. (1815046)
122 usual care.ab. (13020)
123 or/116‐122 (2634734)
124 115 or 123 (3780045)
125 16 and 71 and 106 and 124 (3987)
TABLE 3 Outcomes Framework
Outcome category Measure/construct
Intrinsic Capacity • Mental
• Sensory functions and pain
• Neuro‐musculoskeletal function
• Voice and speech
• Cardiovascular, Haematological, Immune,
Respiratory
• Digestive, Endocrine, Metabolic functions
• Genitourinary, Reproductive function
• Integumentary system function
Functional Ability • Basic needs
• Learning and applying knowledge
• Contribution
• Mobility
• Communication
• Relationships
Process and other • Falls
• Cost (out of pocket)
• Cost‐effectiveness
• Satisfaction
• Access
• Safety
• Caregiver outcomes
• Adherence
• Health Service Utilization
• Quality of Life
• Financial security and stability
• Stigma
Health Inequalities • Place of residence
• Race/Ethnicity
• Occupation
• Gender/sex
• Religion
• Education
• Socioeconomic status
• Social Capital
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executive summary will summarize the report, providing the main
findings and implications for future policy planning and research. The
background will provide a comprehensive description of the burden
of illness and disability among aging older adults and the impact on
functional ability and state the objectives of the EGM. We will also
describe the scope by defining the intervention and outcomes
framework, and theory of change (supplemented by a figure).
Description of the methods will include a definition of the data
sources and methods of searching, the inclusion and exclusion criteria,
study selection, quality appraisal, and data extraction methods and the
approach to presentation/visualization. This section will provide a table
in‐text showing one full search from a database as well as a PRISMA
flow chart. An appendix will provide full search strategies used for each
database, including any restrictions and filters used.
The results section will present the number, type, and quality of
studies retrieved for the main intervention categories, namely,
products and technology related to mobility, and health and social
services at home. We will also present information about how health
equity has been considered in studies, provide an overview of major
evidence gaps based on our framework, and list any limitations. The
conclusion will provide implications for researchers, decision‐makers
and policymakers on the evidence base in this area and the key areas
for the commissioning of future research. We will also include
implications for researchers considering conducting an EGM.
Tables and figures we will include:
• Figure: Conceptual map/theory of change.
• Figure: PRISMA flow chartTable: number of studies by study
design.
• Table: Number of studies by intervention and subcategories.
• Table: Number of studies by population.
5.2 | Filters for presentation
We will present results as a matrix of interventions (rows) and
outcomes (columns) and assess the availability of evidence across the
additional filters of age groups, conditions, equity categories (i.e.,
PROGRESS) and setting.
5.3 | Dependency
When there are multiple reports for a single study, we will treat them
as one study. We acknowledge that SRs are likely to include the RCTs
in the map and there may be more than one SR which includes the
same RCT. All relevant randomized trials will be included regardless
of whether or not it is included in a systematic review.
6 | DATA COLLECTION AND ANALYSIS
6.1 | Screening and study selection
Two reviewers will independently screen the titles and abstracts of
all retrieved articles. Title and abstracts will be screened on the basis
of intervention, study design, and population, and not on the basis of
outcome. Full‐texts of potentially eligible studies will then be
retrieved and screened. The reviewers will compare the results,
and any conflicts will be resolved through discussion or by a third
reviewer. We will not contact authors of studies or reviews for
missing information.
6.2 | Data extraction and management
Two reviewers will independently extract data on published and
ongoing systematic reviews and randomized trials related to the
population, intervention, comparison, and outcomes. Our coding
categories (Appendix) for data extraction will be based on our
intervention/outcomes framework. In addition, we will collect details
on characteristics that may be of interest to decision makers as filters
for the evidence ‐ the country of the study (using WHO regions as
well as the World Bank country classifications by income), age group
(e.g., <65 years, >65 years, etc. ), health conditions (e.g., communic-
able, noncommunicable), study design (e.g., RCT or systematic
review) and setting (e.g., residential home, independent living,
assisted living, or long term care).
We will also collect details, if reported, on health equity as
defined according to the PROGRESS framework ‐ place of residence,
race/ethnicity/language/culture, occupation, gender/sex, religion,
education, socioeconomic status, social capital and other character-
istics associated with disadvantage and vulnerability such as sexual
orientation, age and disability (O'Neill et al., 2014). Furthermore, we
will examine whether studies assessed the effects of the intervention
by gender or any other characteristic of health inequality such as
socioeconomic status. For systematic reviews, we will report equity
characteristics as described, and will not go back to included primary
studies for more details.
6.3 | Tools for assessing risk of bias/study quality
of included reviews
Since systematic reviews are often used for decision making, we
will appraise the quality of systematic reviews with AMSTAR‐2
(Shea, Reeves, & Wells, 2017) in duplicate for 10% of eligible
studies. Kappa statistics will also be used to check agreement for
each item. If the agreement is over 80%, we will proceed with
single data extraction with verification by a second reviewer for
the remainder of studies.
The quality of randomized trials is not usually assessed in EGMs
since the purpose is to identify the randomized trials available, and
not to make decisions based on single trials. As such, we will not
assess the quality of randomized trials (Snilstveit, Bhatia, Rankin, &
Leach, 2017).
6.4 | Methods for mapping
We plan to use the EPPI‐Reviewer 4 software to generate the map
(EPPI‐Centre, 2019).
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APPENDIX
1 Coding Tool
Category Answer
Geographical
information
WHO Regions ‐ South Asia
‐ Sub‐Saharan Africa
‐ East Asia and Pacific
‐ Europe and Central Asia
‐ Latin America and Caribbean
‐ Middle East and North
Africa
‐ North America
World Bank Region
(2019 FY)
‐ Low income economies
‐ Lower Middle income
economies
‐ Upper Middle income
economies
‐ High income economies
Study design Design ‐ Systematic reviews
‐ RCT
Publication status ‐ Complete
‐ On‐going (e.g. Protocols)
Population Age Group ‐ Includes<65 years
‐ Includes>65 years
‐ Includes>75 years
‐ Includes>85 years
Sex/Gender ‐ Includes LGBTQ2 + ‐
Proportion of females
included in study
Health Conditions ‐ Communicable Disease
‐ Non‐communicable disease
‐ Injury
‐ Discharge from hospital
‐ End‐of‐life
‐ Physical Frailty
‐ Social Frailty
‐ Care Dependent
Intervention General Social
support services,
systems and
policies
‐ Homemaking
(Continues)
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‐ Personal Care
‐ Transportation
‐ Family/Caregiver support
‐ Friendly visits
Health services,
systems and
policies
‐ General health services for
disease prevention
‐ Health promotion services
‐ Rehabilitation Services
‐ Long‐term care services
‐ Visiting Health Professionals
‐ Visiting Lay care
providers
Products and
Technology
‐ Personal mobility and
transportation devices
‐ Adaptations to physical
environment
Outcome Intrinsic Capacity ‐ Mental
‐ Sensory functions and pain
‐ Neuro‐musculoskeletal
function
‐ Voice and speech
‐ Cardiovascular,
Haematological, Immune,
Respiratory
‐ Digestive, Endocrine,
Metabolic functions
‐ Genitourinary, Reproductive
function
‐ Integumentary system
function
Functional Ability ‐ Basic needs
‐ Learning and applying
knowledge
‐ Contribution
‐ Mobility
‐ Communication
‐ Relationships
Process and other ‐ Falls
‐ Cost (out of pocket)
‐ Cost‐effectiveness
‐ Satisfaction
‐ Access
(Continues)
‐ Safety
‐ Caregiver outcomes
‐ Adherence
‐ Health Service Utilization
‐ Quality of Life
‐ Financial security and
stability
‐ Stigma
Setting ‐ Residential home/apartment
‐ Long‐term care
‐ Independent living
‐ Assisted Living
Comparison ‐ Usual Care
‐ Other
Systematic Review
quality
‐ High
‐ Moderate
‐ Low
‐ Critically Low
‐ Protocol
PROGRESS ‐ Place of residence
‐ Race/Ethnicity
‐ Occupation
‐ Gender/sex
‐ Religion
‐ Education
‐ Socioeconomic status
‐ Social Capital
Gender
Inequalities
Is there an
assessment of
effects by sex/
gender
‐ Yes
‐ No
‐ Planned but not reported
Other inequalities Is there an
assessment of
effects by other
characteristics, e.g.
socioeconomic
status, income,
race/ethnicity, etc
‐ Yes
‐ No
‐ Planned but not reported
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